[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001]

Gastroenterol Hepatol. 2002 Mar;25(3):162-9. doi: 10.1016/s0210-5705(02)79012-2.
[Article in Spanish]
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Contraindications
  • Crohn Disease / drug therapy*
  • Crohn Disease / physiopathology
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Tumor Necrosis Factor-alpha

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab